BioMark Diagnostics (TSE:BUX) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
BioMark Diagnostics Inc. has announced that research findings on glioblastoma, a challenging brain tumor with limited treatment options, will be presented at the GPEN Conference in Copenhagen. The studies, conducted by the University of Manitoba, include innovative approaches to treatment and the evaluation of BioMark’s liquid biopsy technology for monitoring treatment response.
For further insights into TSE:BUX stock, check out TipRanks’ Stock Analysis page.